SC nominee backed Merck shareholder suit

Want a pharma connection to President Obama's new Supreme Court nominee Elana Kagan? As U.S. Solicitor General, Kagan backed the shareholders who were suing Merck (NYSE: MRK) over claims that the company misrepresented the safety of Vioxx; Kagan agreed that the investors hadn't waited past the statute of limitations to file the lawsuits. Report